Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

NCT03175367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Evinacumab
DRUG: Matching placebo
OTHER: Background Lipid Modifying Therapy (LMT)

Sponsor

Regeneron Pharmaceuticals